The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells

Human Molecular Genetics

Volumn 17, Issue 14, 2008, Pages 2160-2171

  Kyratzi, Elli ^a   Pavlaki, Maria ^a   Stefanis, Leonidas ^a,b  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE; PROTEASOME; SERINE; TYROSINE; UBIQUITIN; UBIQUITIN THIOLESTERASE; UBIQUITIN THIOLESTERASE L1;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN NERVE CELL; BRAIN PROTECTION; CONTROLLED STUDY; DRUG POTENCY; EMBRYO; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT; WILD TYPE;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIOXIDANTS; CELL LINE, TUMOR; CELLS, CULTURED; FEMALE; HUMANS; MALE; MICE; MICE, KNOCKOUT; NEURONS; OXIDATIVE STRESS; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; REACTIVE OXYGEN SPECIES; UBIQUITIN; UBIQUITIN THIOLESTERASE;

MUS;

EID: 46249113267     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn115     Document Type: Article

References (42)

1. Dauer, W. and Przedborski, S. (2003) Parkinson's disease: Mechanisms and models. Neuron, 39, 889-909.
2. Klein, C. and Schlossmacher, M.G. (2007) Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder. Neurology, 69, 2093-2104.
3. Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M.J., Jonnalagada, S., Chemova, T. et al. (1998) The ubiquitin pathway in Parkinson's disease. Nature, 395, 451-452.
4. Maraganore, D.M., Lesnick, T.G., Elbaz, A., Chartier-Harlin, M.C., Gasser, T., Kruger, R., Hattori, N., Mellick, G.D., Quattrone, A., Satoh, J. et al. (2004) UCHL1 is a Parkinson's disease susceptibility gene. Ann. Neurol., 55, 512-521.
5. Elbaz, A., Levecque, C., Clavel, J., Vidal, J.S., Richard, F., Correze, J.R., Delemotte, B., Amouyel, P., Alperovitch, A., Chartier-Harlin, M.C. et al. (2003) S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: Evidence for an age-dependent relationship. Mov. Disord., 18, 130-137.
6. Maraganore, D.M., Farrer, M.J., Hardy, J.A., Lincoln, S.J., McDonnell, S.K., Rocca, W.A. et al. (1999) Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology, 53, 1858-1860.
7. Satoh, I and Kuroda, Y. (2001) A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population. J. Neurol. Sci., 189, 113-117.
8. Carmine Belin, A., Westerlund, M., Bergman, O., Nissbrandt, H., Lind, C., Sydow, O., Galter, D. et al. (2007) S19Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson's disease in Sweden. Parkinsonism Relat. Disord., 13 295-298.
9. Healy, D.G., Abou-Sleiman, P.M., Casas, J.P., Ahmadi, K.R., Lynch, T., Gandhi, S., Muqit, M.M., Foltynie, T., Barker, R., Bhatia, K.P. et al. (2006) UCHL-1 is not a Parkinson's disease susceptibility gene. Ann. Neurol., 59, 627-633.
10. Setsuie, R. and Wada, K. (2007) The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem. Int., 51, 105-111.
11. Liu, Y., Fallon, L., Lashuel, H.A., Liu, Z. and Lansbury, P.T., Jr (2002) The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell, 111, 209-218.
12. Hegde, AX, Inokuchi, K., Pei, W., Casadio, A., Ghirardi, M., Chain, D.G., Martin, K.C., Kandel, E.R., Schwartz, J.H. et al. (1997) Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell, 89, 115-126.
13. Osaka, H., Wang, Y.L., Takada, K., Takizawa, S., Setsuie, R., Li, H., Sato, Y., Nishikawa, K., Sun, Y.J., Sakurai, M. et al. (2003) Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mol. Genet., 12, 1945-1958.
14. Lang-Rollin, I., Rideout, H. and Stefanis, L. (2003) Ubiquitinated inclusions and neuronal cell death. Histol. Histopathol., 18 509-517.
15. Ardley, H.C., Scott, G.B., Rose, S.A., Tan, N.G. and Robinson, P.A. (2004) UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease. J. Neurochem., 90, 379-391.
16. Harada, T., Harada, C., Wang, Y.L., Osaka, H., Amanai, K. Tanaka, K., Takizawa, S., Setsuie, R., Sakurai, M., Sato, Y. et al. (2004) Role of ubiquitin carboxy terminal hydrolase-L1 in neural cell apoptosis induced, by ischemic retinal injury in vivo. Am. J. Pathol., 164, 59-64.
17. Kyratzi, E., Pavlaki, M., Kontostavlaki, D., Rideout, H.J. and Stefanis, L. (2007) Differential effects of Parkin and its mutants on protein aggregation, the ubiquitin-proteasome system, and neuronal cell death in human neuroblastoma cells. J. Neurochem., 102, 1292-1303.
18. Stefanis, L., Park, D.S., Friedman, W.J. and Greene, L.A. (1999) Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons. J. Neurosci.; 19, 6235-6247.
19. Przedborski, S. and Vila, M. (2003) The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: A tool to explore the pathogenesis of Parkinson's disease. Ann. NY Acad. Sci. 991, 189-198.
20. Lang-Rollin, I.C., Rideout, H.J., Noticewala, M. and Stefanis, L. (2003) Mechanisms of caspase-independent neuronal death: Energy depletion and free radical generation. J. Neurosci., 23, 11015-11025.
21. Saigoh, K., Wang, Y.L., Suh, J.G., Yamanishi, T., Sakai, Y., Kiyosawa, H., Harada, T., Ichihara, N., Wakana, S., Kikuchi, T. et al. (1999) Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet., 23, 47-51.
22. Treier, M., Staszewski, L.M. and Bohmann, D. (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78, 787-798.
23. Jariel-Encontre, I., Pariat, M., Martin, F., Carillo, S., Salvat, C., Piechaczyk, M. et al. (1995) Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome. J. Biol. Chem., 270, 11623-11627.
24. Satoh, J.I. and Kuroda, Y. (2001) Ubiquitin C-terminal hydrolase-L1 (PGP9.5) expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines, neurotropbic factors or heat stress. Neuropathol. Appl. Neurobiol., 27, 95-104.
25. Elbaz, A. and Tranchant, C. (2007) Epidemiologic studies of environmental exposures in Parkinson's disease. J. Neurol. Sci., 262, 37-44.
26. Meray, R.K. and Lansbury, P.T., Jr (2007) Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1. J. Biol. Chem., 282, 10567-10575.
27. Setsuie, R., Wang, Y.L., Mochizuki, H., Osaka, H., Hayakawa, H., Ichihara, N., Li, H., Furuta, A., Sano, Y., Sun, Y.J. et al. (2007) Dopaminergic neuronal loss in transgenic mice expressing the Parkinson's disease-associated UCH-L1 I93M mutant. Neurochem. Int. 50, 119-129.
28. Kwon, J., Wang, Y.L., Setsuie, R., Sekiguchi, S., Sato, Y., Sakurai, M., Noda, M., Aoki, S., Yoshikawa, Y., Wada, K. et al. (2004) Two closely related ubiquitin C-terminal hydrolase isozymes function as reciprocal modulators of germ cell apoptosis in cryptorchid testis. Am. J. Pathol., 165, 1367-1374.
29. Choi, J., Levey, A.I., Weintraub, S.T., Rees, H.D., Gearing, M., Chin, L.S., Li, L. et al. (2004) Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J. Biol. Chem. 279, 13256-13264.
30. Gong, B., Cao, Z., Zheng, P., Vitolo, O.V., Liu, S., Staniszewski, A., Moolman, D., Zhang, H., Shelanski, M., Arancio, O. et al. (2006) Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell, 126, 775-788.
31. Gong, B. and Leznik, E. (2007) The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders. Drug News Perspect., 20, 365-370.
32. Naze, P., Vuillaume, I., Destee, A., Pasquier, F. and Sablonniere, B. (2002) Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease. Neurosci. Lett., 328, 1-4.
33. Xue, S. and Jia, J. (2006) Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer's disease in a Chinese Han population. Brain Res., 1087, 28-32.
34. Stefanis, L., Larsen, K.E., Rideout, H.J., Sulzer, D. and Greene, L.A. (2001) Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J. Neurosci., 21, 9549-9560.
35. Jabado, O., Wang, Q., Rideout, H.J., Yeasmin, M., Guo, K.X., Vekrellis, K., Papantonis, S., Angelastro, J.M., Troy, C.M., Stefanis, L. et al. (2004) RAIDD aggregation facilitates apoptotic death of PC12 cells and sympathetic neurons. Cell Death Differ., 11, 618-630.
36. Rideout, H.J., Zang, E., Yeasmin, M., Gordon, R., Jabado, O., Park, D.S., Stefanis, L. et al. (2001) Inhibitors of trypsin-like serine proteases prevent DNA damage-induced neuronal death by acting upstream of the mitochondrial checkpoint-and of p53 induction. Neuroscience 107, 339-352.
37. Rideout, H.J. and Stefanis, L. (2002) Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination. Mol. Cell Neurosci., 21, 223-238.
38. Rukenstein, A., Rydel, R.E. and Greene, L.A. (1991) Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J. Neurosci., 11, 2552-2563.
39. Lecoeur, H., Chauvier, D., Langonne, A., Rebouillat, D., Brugg, B., Mariani, J., Edelman, L., Jacotot, E. et al. (2004) Dynamic analysis of apoptosis in primary cortical neurons by fixed- and real-time cytofluorometry. Apoptosis, 9, 157-169.
40. LeBel, C.P., Ischiropoulos, H. and Bondy, S.C. (1992) Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol., 5 227-231.
41. Hendil, K.B., Khan, S. and Tanaka, K. (1998) Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes. Biochem. J., 332 (Pt 3), 749-754.
42. Hendil, K.B., Hartmann-Petersen, R. and Tanaka, K. (2002) 26 S proteasomes function as stable entities. J. Mol. Biol., 315, 627-636.